XML 13 R2.htm IDEA: XBRL DOCUMENT v3.19.1
CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) - USD ($)
$ in Thousands
Mar. 31, 2019
Dec. 31, 2018
Current assets:    
Cash $ 8,930 $ 10,866
Accounts receivable, net of allowances of $426 and $387 as of March 31, 2019 and December 31, 2018, respectively 15,456 14,952
Inventories 12,460 13,631
Prepaid expenses and other current assets 2,361 2,743
Total current assets 39,207 42,192
Property and equipment, net 2,669 2,624
Operating lease right-of-use assets 5,970  
Intangible assets, net 11,997 10,980
Goodwill 10,441 9,286
Other assets 1,322 1,224
Total assets 71,606 66,306
Current liabilities:    
Accounts payable 6,304 5,654
Current portion - payment obligation 1,050 1,025
Current portion - financial liabilities, net of discount and debt issuance costs of $68 and $25, respectively 11,787 11,554
Operating lease liabilities 2,067  
Notes payable   2,000
Deferred revenue 2,779 2,174
Accrued compensation and related benefits 1,779 1,794
Other accrued expenses and liabilities 4,165 5,277
Total current liabilities 29,931 29,478
Long-term payment obligation 1,569 1,860
Long-term operating lease liabilities 4,072  
Long-term deferred revenue 625 636
Other long-term liabilities 559 632
Total liabilities 36,756 32,606
Commitments and contingencies (see Note 17)
Identiv, Inc. stockholders' equity:    
Common stock, $0.001 par value: 50,000 shares authorized; 17,569 and 17,004 shares issued and 16,479 and 15,967 shares outstanding as of March 31, 2019 and December 31, 2018, respectively 18 17
Additional paid-in capital 446,466 444,145
Treasury stock, 1,090 and 1,047 shares as of March 31, 2019 and December 31, 2018, respectively (8,381) (8,153)
Accumulated deficit (405,168) (404,353)
Accumulated other comprehensive income 2,080 2,209
Total Identiv, Inc. stockholders' equity 35,020 33,870
Noncontrolling interest (170) (170)
Total stockholders´ equity 34,850 33,700
Total liabilities and stockholders' equity 71,606 66,306
Series B Preferred Stock    
Identiv, Inc. stockholders' equity:    
Series B preferred stock, $0.001 par value: 5,000 shares authorized; 5,000 issued and outstanding as of March 31, 2019 and December 31, 2018 5 5
Total stockholders´ equity $ 5 $ 5